Charles River Laboratories International, Inc. (CRL) stock
CRLNYSEServices-Commercial Physical & Biological ResearchFiscal year ends December 27
Financials through Q2 FY2026, quarter ended Jun 27, 2026Last filing: 10-Q on Nov 4, 2026Score 6/30225% above fair value
$333.25+1.09 (+0.33%)
Close on Nov 18, 2026Market cap $15.91BP/E –Yield –
Charles River Laboratories International market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Charles River Laboratories International's market cap was $16.41B on Nov 11, 2026, against $8.77B a year earlier. Over the last 5 years it ranged from $6.07B to $19.01B, with a median of $10.60B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $16.41B | +67.1% |
| 2025 | Dec 31, 2025 | $9.82B | +4.0% |
| 2024 | Dec 31, 2024 | $9.44B | -22.2% |
| 2023 | Dec 29, 2023 | $12.13B | +9.4% |
| 2022 | Dec 30, 2022 | $11.09B | -41.7% |
| 2021 | Dec 31, 2021 | $19.01B | +53.0% |
| 2020 | Dec 31, 2020 | $12.43B | +66.6% |
| 2019 | Dec 31, 2019 | $7.46B | +37.1% |
| 2018 | Dec 31, 2018 | $5.44B | +5.1% |
| 2017 | Dec 29, 2017 | $5.18B | +43.7% |
| 2016 | Dec 30, 2016 | $3.61B | -3.8% |
| 2015 | Dec 31, 2015 | $3.75B | +25.9% |
| 2014 | Dec 31, 2014 | $2.98B | -99.9% |
| 2013 | Dec 31, 2013 | $2.56T | +140844.7% |
| 2012 | Dec 31, 2012 | $1.82B | +33.6% |
| 2011 | Dec 30, 2011 | $1.36B | -33.7% |
| 2010 | Dec 31, 2010 | $2.05B | – |
See a number that looks wrong?